Health Sciences Acquisitions Co. 2 (HSAQ) Competitors $2.97 +0.44 (+17.39%) As of 04/30/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock HSAQ vs. KRMD, MGRM, INFU, OBIO, MBOT, STSS, ICAD, SRTS, NSPR, and INOShould you be buying Health Sciences Acquisitions Co. 2 stock or one of its competitors? The main competitors of Health Sciences Acquisitions Co. 2 include KORU Medical Systems (KRMD), Monogram Orthopaedics (MGRM), InfuSystem (INFU), Orchestra BioMed (OBIO), Microbot Medical (MBOT), Sharps Technology (STSS), iCAD (ICAD), Sensus Healthcare (SRTS), InspireMD (NSPR), and Inovio Pharmaceuticals (INO). These companies are all part of the "surgical & medical instruments" industry. Health Sciences Acquisitions Co. 2 vs. KORU Medical Systems Monogram Orthopaedics InfuSystem Orchestra BioMed Microbot Medical Sharps Technology iCAD Sensus Healthcare InspireMD Inovio Pharmaceuticals KORU Medical Systems (NASDAQ:KRMD) and Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, community ranking, valuation, profitability, dividends, media sentiment, risk and earnings. Does the media favor KRMD or HSAQ? In the previous week, KORU Medical Systems had 4 more articles in the media than Health Sciences Acquisitions Co. 2. MarketBeat recorded 4 mentions for KORU Medical Systems and 0 mentions for Health Sciences Acquisitions Co. 2. KORU Medical Systems' average media sentiment score of 1.07 beat Health Sciences Acquisitions Co. 2's score of 0.00 indicating that KORU Medical Systems is being referred to more favorably in the media. Company Overall Sentiment KORU Medical Systems Positive Health Sciences Acquisitions Co. 2 Neutral Which has more risk & volatility, KRMD or HSAQ? KORU Medical Systems has a beta of 0.87, meaning that its share price is 13% less volatile than the S&P 500. Comparatively, Health Sciences Acquisitions Co. 2 has a beta of 0.09, meaning that its share price is 91% less volatile than the S&P 500. Is KRMD or HSAQ more profitable? Health Sciences Acquisitions Co. 2 has a net margin of 0.00% compared to KORU Medical Systems' net margin of -37.42%. Health Sciences Acquisitions Co. 2's return on equity of 0.00% beat KORU Medical Systems' return on equity.Company Net Margins Return on Equity Return on Assets KORU Medical Systems-37.42% -24.60% -16.87% Health Sciences Acquisitions Co. 2 N/A N/A -2.38% Does the MarketBeat Community favor KRMD or HSAQ? KORU Medical Systems received 45 more outperform votes than Health Sciences Acquisitions Co. 2 when rated by MarketBeat users. CompanyUnderperformOutperformKORU Medical SystemsOutperform Votes4564.29% Underperform Votes2535.71% Health Sciences Acquisitions Co. 2N/AN/A Do analysts recommend KRMD or HSAQ? KORU Medical Systems presently has a consensus target price of $4.70, suggesting a potential upside of 70.91%. Given KORU Medical Systems' stronger consensus rating and higher possible upside, research analysts clearly believe KORU Medical Systems is more favorable than Health Sciences Acquisitions Co. 2.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score KORU Medical Systems 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00Health Sciences Acquisitions Co. 2 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals and insiders believe in KRMD or HSAQ? 58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 89.7% of Health Sciences Acquisitions Co. 2 shares are owned by institutional investors. 20.6% of KORU Medical Systems shares are owned by company insiders. Comparatively, 21.9% of Health Sciences Acquisitions Co. 2 shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has stronger valuation & earnings, KRMD or HSAQ? Health Sciences Acquisitions Co. 2 has lower revenue, but higher earnings than KORU Medical Systems. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKORU Medical Systems$33.65M3.77-$13.74M-$0.12-22.92Health Sciences Acquisitions Co. 2N/AN/A-$380KN/AN/A SummaryKORU Medical Systems beats Health Sciences Acquisitions Co. 2 on 9 of the 15 factors compared between the two stocks. Get Health Sciences Acquisitions Co. 2 News Delivered to You Automatically Sign up to receive the latest news and ratings for HSAQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSAQ vs. The Competition Export to ExcelMetricHealth Sciences Acquisitions Co. 2Surgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$33.30M$4.33B$5.53B$7.93BDividend YieldN/A39.93%5.11%4.22%P/E RatioN/A30.0322.5118.54Price / SalesN/A55.31397.62103.30Price / CashN/A51.0838.1834.62Price / Book-4.796.056.734.25Net Income-$380,000.00$68.71M$3.22B$248.18M7 Day Performance15.12%-0.24%1.38%1.03%1 Month Performance-8.33%-2.90%2.79%2.70%1 Year Performance-46.49%21.00%15.41%4.05% Health Sciences Acquisitions Co. 2 Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSAQHealth Sciences Acquisitions Co. 2N/A$2.97+17.4%N/A-32.5%$33.30MN/A0.004Gap UpHigh Trading VolumeKRMDKORU Medical Systems3.2459 of 5 stars$2.66+7.7%$4.70+76.7%+22.2%$105.20M$33.65M-10.6480Upcoming EarningsNews CoverageMGRMMonogram Orthopaedics2.4493 of 5 stars$2.97+1.0%$5.40+81.8%+47.7%$104.81M$364,999.00-6.3228Gap UpINFUInfuSystem1.4965 of 5 stars$4.94-0.6%$13.00+163.2%N/A$103.82M$134.86M82.35410News CoveragePositive NewsOBIOOrchestra BioMed2.7761 of 5 stars$2.61-6.1%$15.00+474.7%-37.5%$100.00M$2.64M-1.624Gap UpMBOTMicrobot Medical1.8326 of 5 stars$2.69+3.1%$9.00+234.6%+152.1%$93.46MN/A-3.3620Positive NewsSTSSSharps Technology1.1866 of 5 stars$5.68-6.3%N/AN/A$92.78MN/A-0.703High Trading VolumeICADiCAD0.5742 of 5 stars$3.33+1.5%N/A+139.2%$91.13M$19.61M-25.62140SRTSSensus Healthcare2.4947 of 5 stars$4.76+0.4%$13.00+173.1%+19.9%$73.57M$41.81M11.9040Upcoming EarningsNews CoveragePositive NewsNSPRInspireMD2.3203 of 5 stars$2.32-10.4%$4.75+104.7%+32.7%$71.07M$7.01M-3.0950INOInovio Pharmaceuticals3.4621 of 5 stars$1.89+1.1%$12.20+545.5%-83.7%$69.31M$217,756.00-0.47320 Related Companies and Tools Related Companies KORU Medical Systems Competitors Monogram Orthopaedics Competitors InfuSystem Competitors Orchestra BioMed Competitors Microbot Medical Competitors Sharps Technology Competitors iCAD Competitors Sensus Healthcare Competitors InspireMD Competitors Inovio Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSAQ) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Sciences Acquisitions Co. 2 Please log in to your account or sign up in order to add this asset to your watchlist. Share Health Sciences Acquisitions Co. 2 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HSAQ Stock Free HSAQ Stock Alerts